Related Experiment Videos
Candida endophthalmitis in heroin addicts
Documenta Ophthalmologica. Advances in Ophthalmology
|February 28, 1983
Summary
This study describes Candida endophthalmitis in heroin users. Early treatment combining intraocular and systemic antifungal therapy effectively cleared the infection in most cases.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Mycology
Background:
- Endophthalmitis is a severe intraocular inflammation, often sight-threatening.
- Candida albicans is an opportunistic fungal pathogen that can cause endophthalmitis, particularly in intravenous drug users.
- Heroin addiction is associated with an increased risk of endogenous endophthalmitis.
Purpose of the Study:
- To describe the clinical presentation and outcomes of Candida endophthalmitis in heroin addicts.
- To evaluate the efficacy of different treatment modalities for fungal endophthalmitis in this patient population.
Main Methods:
- Retrospective case series of nine eyes in heroin addicts with presumed Candida endophthalmitis.
- Diagnosis confirmed by Candida albicans cultivation from rinsing fluid after pars plana vitrectomy in seven eyes.
- Treatment included intraocular and/or systemic antifungal therapy.
Main Results:
- Pars plana vitrectomy confirmed Candida albicans in six of seven cases.
- Both intraocular and combined local/systemic antifungal therapies were effective in resolving the infection.
- Early initiation of treatment correlated with the most favorable outcomes.
Conclusions:
- Candida endophthalmitis in heroin users can be successfully treated with early antifungal therapy.
- Pars plana vitrectomy aids in diagnosis and can be combined with effective medical treatment.
- Prompt management is crucial for preserving vision in these patients.